With 10 years of research behind us, Cure Alzheimer’s Fund continues to grow, with the quality of our research remaining extraordinary. To build on our success, we recently welcomed four new Research Consortium members and four new employees to our organization.
Cure Alzheimer's Fund is pleased to see the passage of the 21st Centuries Cures Act in the House of Representatives. The overwhelming bipartisan support for the bill shows the need for legislation to improve the process of getting to cures for life-threatening diseases like Alzheimer's.
A recent study by researchers at the University of Virginia suggests previously unknown links between the body's immune system and the brain. According to Cure Alzheimer's Fund Research Consortium chairman Dr. Rudy Tanzi, these findings could be "absolutely game-changing" in the field of Alzheimer's research once confirmed.
David Holtzman, M.D., member of the Cure Alzheimer’s Fund Research Consortium, will receive the 2015 Carl and Gerty Cori Faculty Achievement Award from his home institution, Washington University in St. Louis. The award goes to faculty members who “embody the ideals of individual and collaborative excellence” and “have made significant contributions to their fields,” according to Washington University Chancellor Mark S. Wrighton.
Every year the Cure Alzheimer’s Fund (CAF) Research Consortium members get together with the Board of Directors to discuss their respective research projects, refine their strategy, and leave with a clear mission. This year was no exception.
By the time she was 17, Alexandra Newton had lived in seven different countries and had mastered four different languages. But her family was not surprised when she chose to pursue a career in biochemistry instead of language arts.